A review on anticancer potentials of benzothiazole derivatives.

Benzothiazole is an organic compound bearing a heterocyclic nucleus (thiazole) that imparts a broad spectrum of biological activity to it. The significant and potent activity of benzothiazole moiety influenced distinctively by nature and position of substitutions. This review summarizes of the effect of various substituents in recent trends and approaches to design and develop novel benzothiazole derivatives for anticancer potential in different cell lines by interpreting the structure-activity relationship (SAR) and mechanism of action of a wide range of derivatives. The list of derivatives are categorized in different groups and reviewed for their anticancer activity. The structure-activity relationship for the various derivatives revealed an excellent understanding of benzothiazole moiety in the field of cancer therapy against different cancer cell line. Data obtained from the various articles showed the potential effect of benzothiazole moiety and its derivatives to produce the peculiar and significant lead compound. The important anticancer mechanisms found are tyrosine kinase inhibition, topoisomerase inhibition and induction of apoptosis by reactive oxygen species (ROS) activation. Therefore, the design and development of novel benzothiazole have broad scope in cancer chemotherapy.

[1]  A. Kamal,et al.  Synthesis of 2-anilinopyridyl linked benzothiazole hydrazones as apoptosis inducing cytotoxic agents , 2019, New Journal of Chemistry.

[2]  A. Kamal,et al.  Design and synthesis of DNA-intercalative naphthalimide-benzothiazole/cinnamide derivatives: cytotoxicity evaluation and topoisomerase-IIα inhibition. , 2019, MedChemComm.

[3]  B. Mannervik,et al.  Synthesis and activity mechanism of some novel 2-substituted benzothiazoles as hGSTP1-1 enzyme inhibitors$ , 2017, SAR and QSAR in environmental research.

[4]  A. Doğaner,et al.  Synthesis of 2-Substituted Benzothiazole Derivatives and Their In Vitro Anticancer Effects and Antioxidant Activities Against Pancreatic Cancer Cells. , 2017, Anticancer research.

[5]  C. Kavitha,et al.  A Benzothiazole Derivative (5g) Induces DNA Damage And Potent G2/M Arrest In Cancer Cells , 2017, Scientific Reports.

[6]  Thokhir Basha Shaik,et al.  Synthesis and biological evaluation of cis-restricted triazole/tetrazole mimics of combretastatin-benzothiazole hybrids as tubulin polymerization inhibitors and apoptosis inducers. , 2017, Bioorganic & medicinal chemistry.

[7]  J. D'haese,et al.  Mitochondria and Mitochondrial ROS in Cancer: Novel Targets for Anticancer Therapy , 2016, Journal of cellular physiology.

[8]  Ping Yang,et al.  A novel water-soluble benzothiazole derivative BD926 triggers ROS-mediated B lymphoma cell apoptosis via mitochondrial and endoplasmic reticulum signaling pathways. , 2016, International journal of oncology.

[9]  Meenakshi Singh,et al.  Benzothiazole derivatives bearing amide moiety: potential cytotoxic and apoptosis-inducing agents against cervical cancer , 2016, Anti-cancer drugs.

[10]  Ruiyuan Cao,et al.  Design, Synthesis and Biological Evaluation of Novel Benzothiazole Derivatives as Selective PI3Kβ Inhibitors , 2016, Molecules.

[11]  A. Pae,et al.  Design and synthesis of new potent anticancer benzothiazole amides and ureas featuring pyridylamide moiety and possessing dual B-Raf(V600E) and C-Raf kinase inhibitory activities. , 2016, European journal of medicinal chemistry.

[12]  P. Sahu,et al.  POM analyses and evaluation of in vitro antimicrobial, antitumor activity of 4H-pyrimido[2,1-b]benzothiazole derivatives , 2016, Medicinal Chemistry Research.

[13]  P. Paira,et al.  An efficient green synthesis of 2-arylbenzothiazole analogues as potent antibacterial and anticancer agents. , 2016, Bioorganic & medicinal chemistry letters.

[14]  R. Cetin-Atalay,et al.  Cytotoxic activities of some benzothiazole-piperazine derivatives , 2015, Journal of enzyme inhibition and medicinal chemistry.

[15]  L. Yurttaş,et al.  Synthesis and antitumor activity evaluation of new 2-(4-aminophenyl)benzothiazole derivatives bearing different heterocyclic rings , 2015, Journal of enzyme inhibition and medicinal chemistry.

[16]  F. Maltais,et al.  Structural basis for isoform selectivity in a class of benzothiazole inhibitors of phosphoinositide 3-kinase γ. , 2015, Journal of medicinal chemistry.

[17]  I. Yalcin,et al.  Evaluation of inhibitory effects of benzothiazole and 3-amino-benzothiazolium derivatives on DNA topoisomerase II by molecular modeling studies , 2014, SAR and QSAR in environmental research.

[18]  R. Cetin-Atalay,et al.  Synthesis and cytotoxicity studies of novel benzhydrylpiperazine carboxamide and thioamide derivatives , 2014, Journal of enzyme inhibition and medicinal chemistry.

[19]  L. Yu,et al.  SKLB-163, a new benzothiazole-2-thiol derivative, exhibits potent anticancer activity by affecting RhoGDI/JNK-1 signaling pathway , 2014, Cell Death and Disease.

[20]  Meenakshi Singh,et al.  Benzothiazoles: how relevant in cancer drug design strategy? , 2014, Anti-cancer agents in medicinal chemistry.

[21]  I. Yalcin,et al.  Benzothiazole derivatives as human DNA topoisomerase IIα inhibitors , 2013, Medicinal Chemistry Research.

[22]  R. Cetin-Atalay,et al.  Cytotoxic Activities of some Novel Benzhydrylpiperazine Derivatives , 2013, Drug Research.

[23]  H. Rajak,et al.  Medicinal significance of benzothiazole scaffold: an insight view , 2013, Journal of enzyme inhibition and medicinal chemistry.

[24]  N. Milton,et al.  Kisspeptin prevention of amyloid-β peptide neurotoxicity in vitro. , 2012, ACS chemical neuroscience.

[25]  M. Ingelman-Sundberg,et al.  The expression of CYP2W1: a prognostic marker in colon cancer. , 2012, Anticancer research.

[26]  F. Guengerich,et al.  Bioactivation of fluorinated 2-aryl-benzothiazole antitumor molecules by human cytochrome P450s 1A1 and 2W1 and deactivation by cytochrome P450 2S1. , 2012, Chemical research in toxicology.

[27]  M. Yarim,et al.  Cancer Cell Cytotoxicities of 1-(4-Substitutedbenzoyl)-4-(4-chlorobenzhydryl)piperazine Derivatives , 2012, International journal of molecular sciences.

[28]  R. Cetin Atalay,et al.  Synthesis of novel 6-(4-substituted piperazine-1-yl)-9-(β-D-ribofuranosyl)purine derivatives, which lead to senescence-induced cell death in liver cancer cells. , 2012, Journal of medicinal chemistry.

[29]  Reddanna Pallu,et al.  Synthesis of novel 2-mercapto benzothiazole and 1,2,3-triazole based bis-heterocycles: their anti-inflammatory and anti-nociceptive activities. , 2012, European journal of medicinal chemistry.

[30]  J. Stables,et al.  Design, synthesis, and anticonvulsant evaluation of some novel 1, 3 benzothiazol-2-yl hydrazones/acetohydrazones , 2011, Medicinal Chemistry Research.

[31]  Kai Hung Tiong,et al.  CYP2S1 and CYP2W1 Mediate 2-(3,4-Dimethoxyphenyl)-5-Fluorobenzothiazole (GW-610, NSC 721648) Sensitivity in Breast and Colorectal Cancer Cells , 2011, Molecular Cancer Therapeutics.

[32]  M. Ingelman-Sundberg,et al.  Colorectal Cancer-Specific Cytochrome P450 2W1: Intracellular Localization, Glycosylation, and Catalytic Activity , 2010, Molecular Pharmacology.

[33]  R. Lesyk,et al.  Synthesis and anticancer activity evaluation of 4-thiazolidinones containing benzothiazole moiety. , 2010, European journal of medicinal chemistry.

[34]  Long-Sen Chang,et al.  Synthesis, and biological evaluation of 2-(4-aminophenyl)benzothiazole derivatives as photosensitizing agents. , 2010, Bioorganic & medicinal chemistry.

[35]  Nikhil D. Amnerkar,et al.  Synthesis, anticonvulsant activity and 3D-QSAR study of some prop-2-eneamido and 1-acetyl-pyrazolin derivatives of aminobenzothiazole. , 2010, European journal of medicinal chemistry.

[36]  Sohail Saeed,et al.  Synthesis, characterization and biological evaluation of some thiourea derivatives bearing benzothiazole moiety as potential antimicrobial and anticancer agents. , 2010, European journal of medicinal chemistry.

[37]  Gurdial Singh,et al.  Synthesis and antitumor activity of optically active thiourea and their 2-aminobenzothiazole derivatives: a novel class of anticancer agents. , 2009, European journal of medicinal chemistry.

[38]  M. Yar,et al.  Synthesis and in vivo diuretic activity of biphenyl benzothiazole-2-carboxamide derivatives. , 2009, Acta poloniae pharmaceutica.

[39]  L. Cipak,et al.  Apoptosis induced by 2-acetyl-3-(6-methoxybenzothiazo)-2-yl-amino-acrylonitrile in human leukemia cells involves ROS-mitochondrial mediated death signaling and activation of p38 MAPK. , 2009, Cancer letters.

[40]  R. Lesyk,et al.  Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity. , 2009, European journal of medicinal chemistry.

[41]  M. Ingelman-Sundberg,et al.  The expression of the novel CYP2W1 enzyme is an independent prognostic factor in colorectal cancer - a pilot study. , 2009, European journal of cancer.

[42]  A. Dixit,et al.  2-Thiazolylimino/heteroarylimino-5-arylidene-4-thiazolidinones as new agents with SHP-2 inhibitory action. , 2008, Journal of medicinal chemistry.

[43]  J. Medina-Franco,et al.  Antidiabetic activity of N-(6-substituted-1,3-benzothiazol-2-yl)benzenesulfonamides. , 2008, Bioorganic & medicinal chemistry letters.

[44]  M. Ingelman-Sundberg,et al.  Expression of CYP2W1 in colon tumors: regulation by gene methylation. , 2007, Pharmacogenomics.

[45]  A. Drzezga,et al.  Metabolically stabilized benzothiazoles for imaging of amyloid plaques. , 2007, Journal of medicinal chemistry.

[46]  J. Stables,et al.  Synthesis and anticonvulsant activity of sulfonamide derivatives-hydrophobic domain. , 2007, Bioorganic & medicinal chemistry letters.

[47]  S. Sukumar,et al.  Benzoylphenylurea sulfur analogues with potent antitumor activity. , 2006, Journal of medicinal chemistry.

[48]  Sang Kook Lee,et al.  Solid phase combinatorial synthesis of benzothiazoles and evaluation of topoisomerase II inhibitory activity. , 2006, Bioorganic & medicinal chemistry.

[49]  M. G. Nascimento,et al.  Synthesis, cytotoxicity, and DNA-topoisomerase inhibitory activity of new asymmetric ureas and thioureas. , 2006, Bioorganic & medicinal chemistry.

[50]  E. Stone,et al.  Antitumor benzothiazoles. 26.(1) 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines. , 2006, Journal of medicinal chemistry.

[51]  X. Ronot,et al.  Piperazinobenzopyranones and phenalkylaminobenzopyranones: potent inhibitors of breast cancer resistance protein (ABCG2). , 2005, Journal of medicinal chemistry.

[52]  E. Sausville,et al.  FLUORINATED 2-(4-AMINO-3-METHYLPHENYL)BENZOTHIAZOLES INDUCE CYP1A1 EXPRESSION, BECOME METABOLIZED, AND BIND TO MACROMOLECULES IN SENSITIVE HUMAN CANCER CELLS , 2004, Drug Metabolism and Disposition.

[53]  R. Lesyk,et al.  4-Thiazolidones: Centenarian History, Current Status and Perspectives for Modern Organic and Medicinal Chemistry , 2004 .

[54]  JAMES C. Wang,et al.  Cellular roles of DNA topoisomerases: a molecular perspective , 2002, Nature Reviews Molecular Cell Biology.

[55]  M. Stevens,et al.  Antitumor benzothiazoles. 16. Synthesis and pharmaceutical properties of antitumor 2-(4-aminophenyl)benzothiazole amino acid prodrugs. , 2002, Journal of medicinal chemistry.

[56]  Z Topcu,et al.  DNA topoisomerases as targets for anticancer drugs , 2001, Journal of clinical pharmacy and therapeutics.

[57]  M. Stevens,et al.  Antitumor benzothiazoles. 14. Synthesis and in vitro biological properties of fluorinated 2-(4-aminophenyl)benzothiazoles. , 2001, Journal of medicinal chemistry.

[58]  E. Sausville,et al.  Role of Cyp1A1 in modulation of antitumor properties of the novel agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203, NSC 674495) in human breast cancer cells. , 2000, Cancer research.

[59]  E. Sausville,et al.  Antitumor benzothiazoles. 8. Synthesis, metabolic formation, and biological properties of the C- and N-oxidation products of antitumor 2-(4-aminophenyl)benzothiazoles. , 1999, Journal of medicinal chemistry.

[60]  K. Paull,et al.  Influence of 2-(4-aminophenyl)benzothiazoles on growth of human ovarian carcinoma cells in vitro and in vivo. , 1998, British Journal of Cancer.

[61]  K. Paull,et al.  2-(4-Aminophenyl)benzothiazoles: novel agents with selective profiles of in vitro anti-tumour activity. , 1998, British Journal of Cancer.

[62]  S Wrigley,et al.  Antitumor benzothiazoles. 3. Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo. , 1996, Journal of medicinal chemistry.

[63]  D. Davies,et al.  Structural studies on bioactive compounds. 23. Synthesis of polyhydroxylated 2-phenylbenzothiazoles and a comparison of their cytotoxicities and pharmacological properties with genistein and quercetin. , 1994, Journal of medicinal chemistry.

[64]  V. Narayanan,et al.  Antiparasitic agents. 5. Synthesis and anthelmintic activities of novel 2-heteroaromatic-substituted isothiocyanatobenzoxazoles and benzothiazoles. , 1982, Journal of medicinal chemistry.

[65]  A. Burger,et al.  Antimalarials. 3. Benzothiazole amino alcohols. , 1968, Journal of medicinal chemistry.

[66]  L. Katz.  Antituberculous Compounds. III. Benzothiazole and Benzoxazole Derivatives , 1953 .